Sourced of - Senator Gerard Rennick - https://www.youtube.com/watch?v=JKx8CnmEVpU Another inconvenient truth out of Senate Estimates when I asked Professor Skerritt why the TGA hadn’t attached a warning label to the C-19 vaccine boxes for people with autoimmune antiphospholipid syndrome (APS). The studies he cherry picked, including the Rheumatology journal article, had no relevance to Natalie’s case. That article was the Sinopharm vaccine from China, not available in Australia and contained no phospholipids. Natalie had two Pfizer jabs and a Moderna booster in February 2022. To our knowledge there have been zero studies on boosters for those with APS, let alone mixing the jabs. The TGA would have known Sweden, Denmark and Finland pulled the Moderna vaccine for anyone under 30 in October 2021. How can Skerritt downplay concerns about a warning label when it could have prevented Natalie’s death? Following the science means not having blinders up. There was and is no evidence to prove that a triple-jabbed young lady like Natalie with APS would be safely jabbed and boosted. That is why she died. The TGA failed her. -- FURTHER READING: In spite of many anecdotal reports on the development of thrombotic events in recipients of COVID-19 vaccines, scientific evidence relying on published cases on peer-reviewed journals is limited. Nevertheless, lessons from pre−COVID-19 vaccines taught that vaccine-related injuries may be identified several years following the date of the vaccine campaign introduction and after a large number of individuals have been vaccinated [76]. In addition, side effects occurring in a minority of people belonging to specific populations (like aPL-positive subjects) may be underestimated. https://www.ncbi.nlm.nih.gov/pmc/arti... Sinopharm study in Rheumatology - https://academic.oup.com/rheumap/arti...